Found 62 matching trials
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment PHASE1 This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Show More Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors PHASE1 This study is an open-label, dose-escalation and expansion, Phase I clinica...
Show More Status
Active Not Recruiting
Location
St Vincent's Hospital Sydney
Learn More & Join Trial
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of Disitam...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors PHASE1 An ascending dose study in patients with solid tumors to evaluate the safet...
Show More Location
Foshan First People's Hospital
Learn More & Join Trial
A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma PHASE3 To evaluate the efficacy of Surufatnib combined with Toripalimab compared w...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer PHASE3 This multicenter, randomized, double-blind phase III study intends to recru...
Show More Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies PHASE1 The primary objective is to assess the safety and tolerability of TAB004 as...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma PHASE1 This study is the single-center, open-label phase I clinical trial to evalu...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection PHASE2 This study will investigate if Toripalimab (A PD-1 Inhibitor) will improve ...
Show More Status
Active Not Recruiting
Location
Zhongshan Hospital,Fudan University
Learn More & Join Trial
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC NA This investigator-initiated study aims to evaluate the effectiveness of min...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial